Calyxt Reports Third Quarter 2021 Financial Results
/PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biotechnology company, today announced financial results for its third quarter ended...
Stay updated with breaking news from Travis Frey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biotechnology company, today announced financial results for its third quarter ended...
/PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the launch of a strategic initiative that will...
On Monday, Tilray, Inc. (NASDAQ:TLRY) and Aphria, Inc. (NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion. Benzinga spoke with Irwin Simon, CEO of the new combined company. Check out the video below: Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23. Jazz Pharmaceuticals (NASDAQ:JAZZ) finalized its acquisition of GW Pharmaceuticals plc. (NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, fo...
Next Generation Premium Soybean Product Line Contains Ultra-Low Levels of Linolenic Acid Positioning it to be the Most Stable Premium Soybean Oil Available on the Market R&D Advancement with Complex
New Hemp Transformation Technology Unlocks Capabilities to Selectively Breed and Deliver Improvements in Hemp Traits for Key Markets Including Protein, Fiber, Advanced Materials and Wellness Patent-Pending